News | May 19, 2023
Gland Pharma posts Q4 FY23 consolidated PAT at Rs. 78.68 Cr
Gland Pharma has reported total income of Rs. 823.95 crores during the period ended March 31, 2023
Gland Pharma has reported total income of Rs. 823.95 crores during the period ended March 31, 2023
Late-breaking data from DCR4Contrast study presented at EuroPCR 2023 and SCAI 2023 also shows an average reduction in the total number of angiograms obtained during each procedure of 26.3%
The company has reported total income of Rs. 604.02 crores during the period ended March 31, 2023
Single dose of Ferric Carboxymaltose (FCM) up to 750 mg of iron can be infused in 15 minutes
This latest audit re-emphasizes Hikal's commitment towards maintaining the best in class quality, compliance and regulatory standards across our manufacturing sites
The facility will have a capacity to manufacture upto 3 million tubes monthly
The company has reported total income of Rs. 149.78 crores during the period ended March 31, 2023
The addition of these two hospitals will provide increased access to specialized pediatric and perinatal care services in the geography
Dr. Reddy's Laboratories has been issued a Form 483 with four observations
Alembic has reported total income of Rs. 39.15 crores during the period ended March 31, 2023
Subscribe To Our Newsletter & Stay Updated
